Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials
Von Buck et al, erschienen in „Mult Scler“ (Vol. 25, Nr. 4, April 2019)
Von Buck et al, erschienen in „Mult Scler“ (Vol. 25, Nr. 4, April 2019)